VA Palo Alto Medical Center Trials

VA Palo Alto Medical Center	Welcome, Profile Billing Logout

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Fearon, William F

RESTORE-MI, NCT03998319: A Study of Low-dose Intracoronary Thrombolytic Therapy in STEMI (Heart Attack) Patients.

Recruiting

445

RoW

Tenecteplase (1/3 systemic weight based dose), TNKase, Sterile water for injection (WFI)

University of Sydney, Genentech, Inc.

STEMI, Elevated IMR (>32)

12/24

12/26

NCT03537742: Cardiac Allograft Vasculopathy Inhibition with Alirocumab

Active, not recruiting

120

alirocumab, Praluent, placebo

Stanford University, National Heart, Lung, and Blood Institute (NHLBI)

Vasculopathy

07/25

08/25

FAME 3, NCT02100722: A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease

Active, not recruiting

N/A

1500

Europe, Canada, US, RoW

FFR guided PCI, Fractional Flow Reserve-Guided PCI, CABG, Resolute Integrity Stent, Resolute Onyx Stent

Stanford University, VZW Cardiovascular Research Center Aalst, Catharina Ziekenhuis Eindhoven, Golden Jubilee National Hospital, University of California, Irvine, Medtronic, Abbott Medical Devices, Genae, King's College Hospital, London, Houston Methodist DeBakey Heart and Vascular Center, Houston

Coronary Disease, Coronary Stenosis

12/20

12/24

FAME2-10yFU, NCT06159231: FAME II-10-year Follow-Up

Completed

N/A

888

Europe, US, RoW

CoreAalst BV, Abbott Medical Devices

Coronary Artery Disease

05/24

CLASP IID, NCT03706833: Edwards PASCAL /IIF Pivotal Clinical Trial

Recruiting

N/A

1247

Europe, Canada, US

Edwards PASCAL System, Transcatheter Mitral Valve repair (TMVr), Abbott Mitraclip System

Edwards Lifesciences

Degenerative Mitral Valve Disease, Mitral Regurgitation, Mitral Insufficiency, Functional Mitral Regurgitation

01/25

04/30

ALL-RISE, NCT05893498: Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment

Recruiting

N/A

1924

Europe, Japan, US, RoW

FFRangio, FFR or NHPR, FFR, iFR RFR, dPR, Pd/Pa

CathWorks Ltd., Cardiovascular Research Foundation, New York

Percutaneous Coronary Intervention

12/24

NCT05312164: Physio-Anatomy Clinical Data Collection Study

Recruiting

N/A

150

HF-OCT Imaging, FFR Pressure Wire, Angiography

Gentuity, LLC

Coronary Stenosis

12/24

Pham, Michael

NCT04837131: A Study to Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients

Terminated

Ixazomib

Michael M. Pham

Systemic Sclerosis, Scleroderma, Diffuse Systemic Sclerosis, Diffuse Scleroderma, Diffuse Cutaneous Systemic Sclerosis, Diffuse Cutaneous Scleroderma, Progressive Systemic Sclerosis, Progressive Scleroderma, Scleroderma, Systemic, Scleroderma, Diffuse, Scleroderma;Progressive, Systemic Sclerosis, Diffuse, Systemic; Sclerosis, Progressive, Scleroderma of Lung, Scleroderma With Pulmonary Involvement, Systemic Sclerosis Pulmonary, Systemic Sclerosis With Lung Involvement, Interstitial Lung Disease, Pulmonary Fibrosis Interstitial

02/24

Baer, Judy

No trials found



	Diseases Companies Products Productz Mechanisms of Action Sites